Overview Yervoy Pregnancy Surveillance Study Status: Recruiting Trial end date: 2024-08-31 Target enrollment: Participant gender: Summary The study is a global safety surveillance study of pregnancy outcomes in women who were exposed to ipilimumab during pregnancy and pediatric outcomes up to 5 years of age Details Lead Sponsor: Bristol-Myers SquibbTreatments: Ipilimumab